Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03184870
Title A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb

pancreatic cancer

colorectal cancer


BMS-813160 + Fluorouracil + Irinotecan + Leucovorin

BMS-813160 + Nivolumab

BMS-813160 + Gemcitabine + Nab-paclitaxel


Age Groups: adult | senior
Covered Countries USA | ESP | DEU | CAN | BEL

No variant requirements are available.